BNP Paribas Asset Management
SRNE

BNP Paribas Asset Management’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

BNP Paribas Asset Management’s Portfolio SRNE Stock Details SRNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-12,310
Closed -$57K – 957
2021
Q4 		$57K Buy
+12,310
New +$57K ﹤0.01% 916